Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 790 | 845 | 13,967 | 3,282 | 7,637 |
| Marketable Securities | 17,272 | 27,579 | 21,708 | 7,779 | 9,387 |
| Receivables | 361 | 138 | 0 | 0 | 0 |
| Other current assets | 327 | 194 | 222 | 247 | 133 |
| TOTAL | $18,750 | $28,756 | $35,897 | $11,309 | $17,157 |
| Non-Current Assets | |||||
| PPE Net | 2,431 | 2,953 | 1,909 | 2,388 | 3,080 |
| Other Non-Current Assets | 641 | 41 | 34 | 34 | 38 |
| TOTAL | $3,072 | $2,994 | $1,943 | $2,422 | $3,118 |
| Total Assets | $21,822 | $31,751 | $37,840 | $13,731 | $20,275 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 297 | 294 | 146 | 156 | 269 |
| Accrued Expenses | 1,230 | 1,083 | 1,051 | 731 | 373 |
| Other current liabilities | 0 | 0 | 13 | 75 | 50 |
| TOTAL | $1,527 | $1,376 | $1,210 | $962 | $691 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,527 | $1,376 | $1,210 | $962 | $691 |
| Shareholders' Equity | |||||
| Common Shares | 78 | 78 | 77 | 54 | 54 |
| Retained earnings | -50,260 | -39,934 | -32,786 | -24,134 | -16,898 |
| Other shareholders' equity | -76 | -214 | -254 | -632 | -1,068 |
| TOTAL | $20,296 | $30,375 | $36,631 | $12,769 | $19,584 |
| Total Liabilities And Equity | $21,823 | $31,751 | $37,841 | $13,731 | $20,275 |